Head of the Sickle cell and Red cell diseases referral center (UMGGR), Univ Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, Créteil, France 
Coordinator of French referral and competence centers of rare blood cell diseases.
Head of the research group “Sickle cell disease and hemolysis”. IMRB, INSERM – UPEC – EFS, Laboratory of excellence, Créteil, France 
Clinical Investigation Center 1430, Henri Mondor, APHP, Créteil, France   

Professor Bartolucci is a distinguished physician and researcher specializing in sickle cell disease and other rare red blood cell disorders. His work is widely recognized, with over 150 publications in leading international journals. He earned his M.D. in Internal Medicine in 2003, followed by two master’s degrees in immunology, and in physiology and biology of circulation and respiration. He also completed his Ph.D. in 2010. 

He currently serves as the director of the Coordinating Referral Center for Sickle Cell and Rare Red Blood Cell Diseases at the Henri Mondor University Hospital (APHP - UPEC). The center oversees the care of more than 3,000 patients and coordinates activities across 17 reference centers and 38 competence centers. 

Professor Bartolucci leads a research group focused on sickle cell disease and hemolysis (IMRB, INSERM - UPEC - EFS, laboratory of excellence). This group is involved in two programs studying anemia in space, coordinated by Professor Guy Trudel from the University of Ottawa.

With a track record of being the principal investigator in over 40 clinical trials, he also leads the research group of the French Network MCGRE. Additionally, He has led the Hemoglobinopathies Subcommittee of the DIM for Gene Therapy, coordinated by Professor Cavazzana. As a Professor of Internal Medicine, he imparts his knowledge and expertise through teaching in five postgraduate courses in France and Africa.  In 2019, he co-founded INNOVHEM, a company dedicated to improving the management of sickle cell disease and hemolysis.